Insider Transactions in Q4 2021 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Tobin Schilke CFO |
BUY
Other acquisition or disposition
|
Direct |
404
+0.59%
|
$5,252
$13.87 P/Share
|
|
Dec 15
2021
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
513
-0.5%
|
$7,695
$15.92 P/Share
|
|
Dec 15
2021
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,556
-2.25%
|
$23,340
$15.92 P/Share
|
|
Dec 13
2021
|
Angus C. Russell Director |
BUY
Open market or private purchase
|
Direct |
6,400
+19.21%
|
$96,000
$15.74 P/Share
|
|
Dec 03
2021
|
Aubrey Rankin Director |
BUY
Open market or private purchase
|
Direct |
30,000
+23.91%
|
$420,000
$14.43 P/Share
|
|
Nov 29
2021
|
Mark J Foley CEO |
BUY
Open market or private purchase
|
Indirect |
40,000
+26.51%
|
$480,000
$12.9 P/Share
|
|
Nov 09
2021
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
35,920
+26.06%
|
-
|
|
Oct 13
2021
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
42,096
-5.19%
|
$968,208
$23.08 P/Share
|